Companies Investors People

Drop to look up

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing
For Startups
Alternatives

For iPhone and iPad

Resources

Documentation
Use Cases
CLI
MCP
Sitemap

aVenture is an AI-native agentic deep research tool for researching and finding companies and people, and is a high-quality alternative to AlphaSense, CB Insights, Crunchbase, Dealroom, Harmonic, Owler, Perplexity Finance, PitchBook, Preqin, PrivCo, Synaptic, and Tracxn.

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Terms of service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Day One Biopharmaceuticals/

Library

Day One Biopharmaceuticals

: 2018

Day One Biopharmaceuticals Website, Blog & Press Pages - aVenture Research

Library

dayonebio.comCrawled Nov 11, 2026

Topics

Publication type

Search the library

Content origin

Row density

Product

6 pages

Clinical Trials/our-science/clinical-trials
Learn more about clinical trials at Day One including FIREFLY-1, FIREFLY-2, and DAY301-001.
Investigator-Sponsored Research/our-science/investigator-sponsored
Day One supports Investigator-Sponsored Trials (ISTs) that advance scientific knowledge in pediatric & adult oncology. Submit a proposal for consideration.
Our Medicine/our-medicine
The page describes an approved targeted therapy and the EveryDay Support program for families.
Our Science/our-science
Day One is focused on advancing first- or best-in-class medicines for people of all ages including tovorafenib, DAY301, and VRK1 Program.

Blog

6 pages

A First-in-Class Opportunity with Emi-Le, A Novel ADC/a-first-in-class-opportunity-with-emi-le-a-novel-adc
Giving New Life to Medicines and Options to Patients/giving-new-life-to-medicines-article
Davy Chiodin, Chief Development Officer, reflects on Day One's start and how one treatment's long journey to patients has now put the company in the position to hopefully help more people with cancer.
Jeremy Bender on Biotech2050/jeremy-bender-on-biotech2050
Day One’s CEO discusses transforming pediatric cancer care & leading biotech with purpose.
Kids With Brain Tumors Deserve Better/kids-with-brain-tumors-deserve-better

Press

1 page

Day One's Next Chapter in Oncology Innovation/day-ones-next-chapter-in-oncology-innovation
Jeremy Bender, CEO, reflects on JPM Healthcare Conference, highlights Day One's significant progress, & shares exciting opportunities for 2025.

Careers & Hiring

5 pages

Benefits That Matter/careers/benefits-that-matter
Day One offers competitive Bay Area compensation, comprehensive medical, dental, and vision plans, annual wellness stipend, flexible PTO, 4-day holiday weekends.
Inclusion & belonging/careers/inclusion-belonging
Day One Biopharmaceuticals prioritizes inclusion and community engagement to drive industry change.
Join Us to Make a Difference/careers/overview-careers
Located in the Bay Area, Day One has a remote-hybrid working model. Learn more about what makes Day One a great place to work.
Open positions/careers/open-positions

Team

1 page

Our patient advocacy team/patients/our-advocacy-team
The advocacy team at Day One works to ensure that the perspectives of patients and families inform company decision-making at every level.

About

5 pages

Ethics & Integrity/our-company/compliance
Day One Biopharmaceuticals emphasizes compliance as part of its mission to deliver life-changing treatments for all ages.
Executive Insights/our-company/executive-insights
Thought-leadership and perspectives from Day One's executive team.
Mission/our-company/mission-strategy
Our Company/our-company

Contact

1 page

Contact Us/our-company/contact-us

Homepage

1 page

Homepage/
Day One Biopharmaceuticals aims to accelerate drug development for children and adults with cancer.

Privacy

1 page

Privacy Notice/privacy-notice
Day One Biopharmaceuticals outlines its privacy practices for personal information collected through its website and interactions.

Terms & Conditions

1 page

Terms of use/terms-of-use